Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Brain

Topics

Medicine

Pathology

Physiology

Neurology

Psychiatry And Mental Health

Show all topics

DOI

10.1093/brain/awab223

License

CC-BY-NC

Other Formats

PDF